168 related articles for article (PubMed ID: 22367361)
1. Replication study for reported SNP associations with breast cancer survival.
Beeghly-Fadiel A; Zheng W; Lu W; Long J; Zheng Y; Cai H; Gu K; Chen Z; Cai Q; Gao YT; Shu XO
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1019-26. PubMed ID: 22367361
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in the MMP-7 gene and breast cancer survival.
Beeghly-Fadiel A; Shu XO; Long J; Li C; Cai Q; Cai H; Gao YT; Zheng W
Int J Cancer; 2009 Jan; 124(1):208-14. PubMed ID: 18798254
[TBL] [Abstract][Full Text] [Related]
3. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.
Dorjgochoo T; Zheng Y; Gao YT; Ma X; Long J; Bao P; Zhang B; Wen W; Lu W; Zheng W; Shu XO; Beeghly-Fadiel A
Cancer Epidemiol; 2013 Oct; 37(5):619-24. PubMed ID: 23850146
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
5. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Harvey VJ; Neven P; Treilleux I; Rasmussen BB; Maibach R; Price KN; Coates AS; Goldhirsch A; Pagani O; Viale G; Rae JM; Regan MM
Breast Cancer Res Treat; 2015 Jun; 151(2):373-84. PubMed ID: 25935582
[TBL] [Abstract][Full Text] [Related]
6. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
Decock J; Long JR; Laxton RC; Shu XO; Hodgkinson C; Hendrickx W; Pearce EG; Gao YT; Pereira AC; Paridaens R; Zheng W; Ye S
Cancer Res; 2007 Nov; 67(21):10214-21. PubMed ID: 17974962
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
8. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
10. The influence of functional polymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients in a Chinese population.
Fu F; Wang C; Chen LM; Huang M; Huang HG
DNA Cell Biol; 2013 May; 32(5):274-82. PubMed ID: 23570558
[TBL] [Abstract][Full Text] [Related]
11. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
He X; Yao G; Li F; Li M; Yang X
Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
[TBL] [Abstract][Full Text] [Related]
12. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
[TBL] [Abstract][Full Text] [Related]
13. A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
Sawyer MB; Pituskin E; Damaraju S; Bies RR; Vos LJ; Prado CM; Kuzma M; Scarfe AG; Clemons M; Tonkin K; Au HJ; Koski S; Joy AA; Smylie M; King K; Carandang D; Damaraju VL; Hanson J; Cass CE; Mackey JR
Clin Breast Cancer; 2016 Apr; 16(2):139-44.e1-3. PubMed ID: 26452313
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
15. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival.
Song N; Choi JY; Sung H; Jeon S; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D
PLoS One; 2015; 10(4):e0123994. PubMed ID: 25875532
[TBL] [Abstract][Full Text] [Related]
16. The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer.
Hsiao CL; Liu LC; Shih TC; Chuang CL; Chen GL; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Way TD; Chung JG; Bau DT
Anticancer Res; 2018 Apr; 38(4):2181-2185. PubMed ID: 29599337
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
18. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
19. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
20. Risk Association of
Solis-Coronado O; Villarreal-Vela MP; Rodríguez-Gutiérrez HF; González-Guerrero JF; Cerda-Flores RM; Alcorta-Núñez F; Camarillo-Cárdenas KP; Pérez-Ibave DC; Vidal-Gutiérrez O; Ramírez-Correa GA; Garza-Rodríguez ML
Curr Oncol; 2022 Feb; 29(2):1008-1017. PubMed ID: 35200585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
